Skip to main content
. 2017 Oct 9;8(60):101760–101770. doi: 10.18632/oncotarget.21667

Figure 2. MiR-92a induces resistance to 5-FU treatment in CRC cells.

Figure 2

(A, B) MTT and DNA fragmentation assays were performed in miR-92a and control expressing cells treated with different concentrations of 5-FU for 72 h. (C) Western blot analysis of cleaved PARP (C-PARP) and PARP in miR-92a-expressing and control CRC cells after treatment with 10 μg/ml 5-FU for 72 h. (D) Flow cytometric analysis of miR-92a overexpression and control CRC cells treated with indicated concentrations of 5-FU. *P < 0.05, #not significance.